Boston-area researchers have shown that inhibiting a cation channel dubbed TRPV4 induced white fat cells to behave like brown fat, thereby protecting mice from diet-induced obesity and insulin resistance. Ember Therapeutics has options to in-license the findings as a part of a trio of new deals for brown fat-related targets.